Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
97
97 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials
Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)
- ABSK043Phase 24 trials
Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer
- IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials
Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma
- BalstilimabAGEN2034Phase 23 trials
ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
- BT5528nuzefatide pevedotinPhase 23 trials
BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer
- JPI-547Phase 23 trials
Onconic Therapeutics Inc. · Pancreatic Ductal Adenocarcinoma, Gastric Cancer (GC), Ovarian Cancer
- PD-L1 t-haNKPhase 23 trials
ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer
- SSGJ-706Phase 23 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)
- ABSK061Phase 22 trials
Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer
- and oxaliplatinPhase 22 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
- Carboplatin AUC-5Phase 22 trials
Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer
- DenikitugGS-1811, DENPhase 22 trials
Gilead Sciences · Advanced Microsatellite Stable Colorectal Cancer, HER2-negative, Gastroesophageal Junction
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- OsrhCTRecombinant Human Chymotrypsin 4000UPhase 22 trials
Healthgen Biotechnology Corp. · Gastric Mucosal Lesion
- rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials
Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer
- S095029Phase 22 trials
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer
- SAR445877Phase 22 trials
Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma
- TCC1727Phase 22 trials
Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
- TRK-950Phase 22 trials
Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
- TST001Phase 22 trials
Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
- XNW27011ASP546CPhase 22 trials
Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
- APL-101Phase 21 trial
Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer
- AST-301pNGVL3-hICDPhase 21 trial
Aston Sci. Inc. · Gastric Cancer
- AZD4360Phase 21 trial
AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer
- AZD5863Phase 21 trial
AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD7789Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
- BDC-4182Phase 21 trial
Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
- BHB810Phase 21 trial
BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer
- CBX-12Phase 21 trial
Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma
- CR-002Phase 21 trial
Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)
- CR6086vorbipiprantPhase 21 trial
Rottapharm Biotech · Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer
- CT041Phase 21 trial
CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer
- EIK1005Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer
- IDX-1197Phase 21 trial
Idience Co., Ltd. · Gastric Cancer
- LUM015Phase 21 trial
Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MDX2001Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- NDI-101150Phase 21 trial
Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- NEO212POH-TMZPhase 21 trial
Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult
- Q702Phase 21 trial
Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer
- SL-28Phase 21 trial
Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- SYS6062Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)
- TH9619Phase 21 trial
One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.